The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc. Chief Executive Officer Stephane Bancel said at a Goldman Sachs-organized healthcare conference on January 6.
Leading U.S. infectious disease specialist Dr. Anthony Fauci said he foresees America achieving enough collective Covid-19 immunity through vaccinations to regain “some semblance of normality” by autumn 2021, despite early setbacks in the vaccine rollout.
Blocking TNF production could offer a more effective solution for the treatment of COVID-19.
The number of new Covid-19 cases in the United States last week rose 13% to more than 393,000, approaching levels last seen during the summer peak, according to a Reuters analysis.
The United States surpassed 170,000 coronavirus deaths, according to a Reuters tally, as health officials express concerns over Covid-19 complicating the fall flu season.
Healthcare providers – including CVS Health Corp. – are kicking off flu vaccinations early, ordering extra shots and aiming to add tests that check for both the annual flu and COVID-19, pharmacy executives and experts told Reuters.
First indications of the effectiveness of a potential vaccine against coronavirus may be available in the autumn, the head of the GAVI vaccine alliance told a Swiss newspaper, forecasting a long road from there to broad availability.